Most Active Stories
- Here's Why UAW Thinks This New Push In Chattanooga Will Be Different
- Did Cleveland, TN Really Redefine 'Mile High Club' With $42 Million in Pork?
- UnifiEd is Hosting Debates With the District 5 and District 9 School Board Candidates
- Patrick Johnston: The Odyssey of a Soccer Junkie
- Signal Mountain Playhouse Presents 'The King and I' Throughout July
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.